Ligand validation:3W8L

IHP: INOSITOL HEXAKISPHOSPHATE

IHP is a Ligand Of Interest in 3W8L designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3W8L_IHP_B_501	42%	55%	0.147	0.867	0.78	0.96	-	-	0	0	100%	1
3W8L_IHP_B_500	41%	52%	0.162	0.879	0.76	1.1	-	4	0	0	100%	1
5CVH_IHP_A_402	65%	28%	0.099	0.901	1.19	1.85	3	14	0	0	100%	0.5
5MPJ_IHP_A_402	12%	56%	0.247	0.775	0.75	0.94	-	-	1	0	100%	0.5
5MOE_IHP_A_404	10%	54%	0.221	0.729	0.73	1.04	-	1	0	0	100%	0.5
5OQU_IHP_A_408	10%	50%	0.241	0.742	1.13	0.82	3	1	0	0	100%	0.5
5ORJ_IHP_A_407	6%	35%	0.355	0.792	1.06	1.6	-	8	0	0	100%	1
1ZY7_IHP_A_901	99%	48%	0.055	0.989	0.99	1.03	2	2	0	0	100%	1
3HO6_IHP_A_270	97%	29%	0.072	0.985	2.06	0.91	15	2	0	0	100%	1
4LV7_IHP_A_501	92%	41%	0.093	0.986	1.11	1.25	1	6	0	0	100%	1
3EEB_IHP_B_210	92%	52%	0.091	0.983	0.86	1.01	-	-	0	0	100%	1
3PEE_IHP_B_256	91%	49%	0.099	0.988	0.87	1.1	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.